Provided by Tiger Trade Technology Pte. Ltd.

Exact Sciences

104.91
0.0000
Volume:- -
Turnover:2.26B
Market Cap:20.02B
PE:-95.19
High:104.91
Open:104.91
Low:104.91
Close:104.91
52wk High:104.98
52wk Low:38.81
Shares:190.81M
Float Shares:187.46M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1021
EPS(LYR):-1.1021
ROE:-8.66%
ROA:-1.59%
PB:8.34
PE(LYR):-95.19

Loading ...

Exact Sciences Cut to Neutral From Outperform by Mizuho

Dow Jones
·
Jan 20

Mizuho Downgrades Exact Sciences to Neutral From Outperform, Adjusts Price Target to $105 From $85

MT Newswires Live
·
Jan 20

Exact Sciences Corp : Mizuho Cuts to Neutral From Outperform; Raises Target Price to $105 From $85

THOMSON REUTERS
·
Jan 20

Exact Sciences downgraded to Neutral from Outperform at Mizuho

TIPRANKS
·
Jan 20

FACTBOX-Major deals involving U.S. drugmakers and biotechs over the past decade

Reuters
·
Jan 15

Press Release: MDxHealth Reports Preliminary Fourth Quarter and Full Year 2025 Revenues, Issues 2026 Revenue Guidance, and Amends Earnout Terms with Exact Sciences

Dow Jones
·
Jan 12

Clinical Labs Hope to Head Off Looming Medicare Cuts -- Barrons.com

Dow Jones
·
Jan 10

Exact Sciences Sets February 20, 2026 Virtual Meeting for Shareholder Vote on $105-per-Share Abbott Merger

TIPRANKS
·
Jan 09

Exact Sciences Cut to In-Line From Outperform by Evercore ISI Group

Dow Jones
·
Jan 06

It’s Earnings Warning Season. How to Profit From Others’ Misery

Dow Jones
·
Jan 01

ADVISORY-Alert from law firm on Exact Sciences-Abbott deal withdrawn

Reuters
·
Dec 30, 2025

Exact Sciences Shareholders Unhappy With $105 per Share Sale to Abbott Should Contact Julie & Holleman Llp Regarding Potential Claims

THOMSON REUTERS
·
Dec 30, 2025

Exact Sciences Approves Accelerated Bonus and Equity Vesting for Executives Ahead of Abbott Merger

Reuters
·
Dec 29, 2025

Exact Sciences Enrolls First Participant in Japan CRANE Study for Blood-Based Cancer Detection Test

Reuters
·
Dec 19, 2025

Is Exact Sciences (EXAS) Still Undervalued After Its Recent Share Price Surge?

Simply Wall St.
·
Dec 15, 2025

Exact Sciences Unveils Promising Oncodetect MRD Test Results in Early Triple-Negative Breast Cancer Study

Reuters
·
Dec 12, 2025

Exact Sciences, the Nsabp Foundation, and the German Breast Group Present Results for the Oncodetect® Mrd Test in Early Triple-Negative Breast Cancer at Sabcs

THOMSON REUTERS
·
Dec 12, 2025

Illumina Partners with MyOme to Advance AI-Driven Genomic Health Solutions

Reuters
·
Dec 11, 2025

Why Is Adaptive Biotechnologies Stock Trading Lower After Natera's Over $400 Million Deal?

Benzinga_recent_news
·
Dec 06, 2025

Assessing Abbott After 10.5% Gains and DCF PE Signals Amid Exact Sciences Deal Talk

Simply Wall St.
·
Dec 05, 2025